• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲硫氨酸-Mettl3-N6-甲基腺苷轴促进多囊肾病。

A methionine-Mettl3-N-methyladenosine axis promotes polycystic kidney disease.

机构信息

Department of Internal Medicine and Division of Nephrology, UT Southwestern Medical Center Dallas, TX 75390, USA.

Department of Anesthesiology and Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Cell Metab. 2021 Jun 1;33(6):1234-1247.e7. doi: 10.1016/j.cmet.2021.03.024. Epub 2021 Apr 13.

DOI:10.1016/j.cmet.2021.03.024
PMID:33852874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8172529/
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenic disorder marked by numerous progressively enlarging kidney cysts. Mettl3, a methyltransferase that catalyzes the abundant N-methyladenosine (mA) RNA modification, is implicated in development, but its role in most diseases is unknown. Here, we show that Mettl3 and mA levels are increased in mouse and human ADPKD samples and that kidney-specific transgenic Mettl3 expression produces tubular cysts. Conversely, Mettl3 deletion in three orthologous ADPKD mouse models slows cyst growth. Interestingly, methionine and S-adenosylmethionine (SAM) levels are also elevated in ADPKD models. Moreover, methionine and SAM induce Mettl3 expression and aggravate ex vivo cyst growth, whereas dietary methionine restriction attenuates mouse ADPKD. Finally, Mettl3 activates the cyst-promoting c-Myc and cAMP pathways through enhanced c-Myc and Avpr2 mRNA mA modification and translation. Thus, Mettl3 promotes ADPKD and links methionine utilization to epitranscriptomic activation of proliferation and cyst growth.

摘要

常染色体显性多囊肾病(ADPKD)是一种常见的单基因疾病,其特征是大量逐渐增大的肾囊肿。Mettl3 是一种甲基转移酶,可催化丰富的 N6-甲基腺苷(m6A)RNA 修饰,参与发育过程,但在大多数疾病中的作用尚不清楚。在这里,我们表明 Mettl3 和 mA 水平在小鼠和人类 ADPKD 样本中增加,并且肾脏特异性转基因 Mettl3 表达可产生管状囊肿。相反,在三种同源 ADPKD 小鼠模型中敲除 Mettl3 可减缓囊肿生长。有趣的是,ADPKD 模型中的蛋氨酸和 S-腺苷甲硫氨酸(SAM)水平也升高。此外,蛋氨酸和 SAM 诱导 Mettl3 表达并加重体外囊肿生长,而饮食中蛋氨酸限制可减轻小鼠 ADPKD。最后,Mettl3 通过增强 c-Myc 和 Avpr2 mRNA m6A 修饰和翻译来激活促进囊肿形成的 c-Myc 和 cAMP 途径。因此,Mettl3 促进了 ADPKD 的发生,并将蛋氨酸利用与增殖和囊肿生长的表观转录组激活联系起来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/b2d5b62f5a8a/nihms-1688926-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/36788c71ced3/nihms-1688926-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/e10525ae0bed/nihms-1688926-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/f7a026334438/nihms-1688926-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/3a51562fa6f1/nihms-1688926-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/764c4f8bd414/nihms-1688926-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/b2d5b62f5a8a/nihms-1688926-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/36788c71ced3/nihms-1688926-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/e10525ae0bed/nihms-1688926-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/f7a026334438/nihms-1688926-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/3a51562fa6f1/nihms-1688926-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/764c4f8bd414/nihms-1688926-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c48/8172529/b2d5b62f5a8a/nihms-1688926-f0007.jpg

相似文献

1
A methionine-Mettl3-N-methyladenosine axis promotes polycystic kidney disease.甲硫氨酸-Mettl3-N6-甲基腺苷轴促进多囊肾病。
Cell Metab. 2021 Jun 1;33(6):1234-1247.e7. doi: 10.1016/j.cmet.2021.03.024. Epub 2021 Apr 13.
2
The N-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy.N6-甲基腺苷 mRNA 甲基转移酶 METTL3 控制心脏稳态和肥大。
Circulation. 2019 Jan 22;139(4):533-545. doi: 10.1161/CIRCULATIONAHA.118.036146.
3
METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.METTL3 通过 Fasn mRNA 的 N6-甲基腺苷修饰抑制肝胰岛素敏感性并促进脂肪酸代谢。
Biochem Biophys Res Commun. 2019 Oct 8;518(1):120-126. doi: 10.1016/j.bbrc.2019.08.018. Epub 2019 Aug 10.
4
mA RNA methylation drives kidney fibrosis by upregulating β-catenin signaling.m⁶A RNA 甲基化通过上调 β-连环蛋白信号转导促进肾纤维化。
Int J Biol Sci. 2024 Jun 3;20(8):3185-3200. doi: 10.7150/ijbs.96233. eCollection 2024.
5
METTL3-Mediated N 6 -Methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis.METTL3 介导的 N6 -甲基腺苷 mRNA 修饰和肾脏纤维化中的 cGAS-STING 通路活性。
J Am Soc Nephrol. 2024 Oct 1;35(10):1312-1329. doi: 10.1681/ASN.0000000000000428. Epub 2024 Jun 10.
6
The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.m6A 甲基转移酶 METTL3 介导的 DEK mRNA 的 N6-甲基腺苷化修饰促进胃癌细胞生长和转移。
Int J Mol Sci. 2022 Jun 9;23(12):6451. doi: 10.3390/ijms23126451.
7
The mA methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network.m6A 甲基转移酶 METTL3 通过 AFF4/NF-κB/MYC 信号网络促进膀胱癌的进展。
Oncogene. 2019 May;38(19):3667-3680. doi: 10.1038/s41388-019-0683-z. Epub 2019 Jan 18.
8
METTL3-mediated N-methyladenosine mRNA modification enhances long-term memory consolidation.METTL3 介导的 N6-甲基腺苷 mRNA 修饰增强长时程记忆巩固。
Cell Res. 2018 Nov;28(11):1050-1061. doi: 10.1038/s41422-018-0092-9. Epub 2018 Oct 8.
9
Dynamic mA mRNA methylation reveals the role of METTL3-mA-CDCP1 signaling axis in chemical carcinogenesis.动态 mA mRNA 甲基化揭示了 METTL3-mA-CDCP1 信号轴在化学致癌中的作用。
Oncogene. 2019 Jun;38(24):4755-4772. doi: 10.1038/s41388-019-0755-0. Epub 2019 Feb 22.
10
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.YTHDF2 通过 N6-甲基腺苷依赖性方式介导肿瘤抑制因子的 mRNA 降解,从而诱导前列腺癌中 AKT 的磷酸化。
Mol Cancer. 2020 Oct 29;19(1):152. doi: 10.1186/s12943-020-01267-6.

引用本文的文献

1
The role of N6-methyladenosine (mA) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential.N6-甲基腺苷(m⁶A)RNA甲基化修饰在肾脏疾病中的作用:从机制到治疗潜力
PeerJ. 2025 Aug 27;13:e19940. doi: 10.7717/peerj.19940. eCollection 2025.
2
MR Promotes Ferroptosis in Gastric Cancer by Regulating FANCD2 Expression Mediated by m6A Modification.MR通过调控m6A修饰介导的FANCD2表达促进胃癌铁死亡
Appl Biochem Biotechnol. 2025 Aug 12. doi: 10.1007/s12010-025-05355-5.
3
Decoding mA RNA methylation in kidney disorders: from molecular insights to therapeutic strategies.

本文引用的文献

1
HBXIP promotes gastric cancer METTL3-mediated MYC mRNA m6A modification.HBXIP 通过促进胃癌 METTL3 介导的 MYC mRNA m6A 修饰来促进肿瘤发生。
Aging (Albany NY). 2020 Oct 13;12(24):24967-24982. doi: 10.18632/aging.103767.
2
Roles of N6-Methyladenosine (mA) in Stem Cell Fate Decisions and Early Embryonic Development in Mammals.N6-甲基腺嘌呤(mA)在哺乳动物干细胞命运决定和早期胚胎发育中的作用。
Front Cell Dev Biol. 2020 Aug 11;8:782. doi: 10.3389/fcell.2020.00782. eCollection 2020.
3
Life span extension by glucose restriction is abrogated by methionine supplementation: Cross-talk between glucose and methionine and implication of methionine as a key regulator of life span.
解析肾脏疾病中的mRNA甲基化:从分子洞察到治疗策略
J Transl Med. 2025 Jul 10;23(1):771. doi: 10.1186/s12967-025-06817-4.
4
Wheat-Based Protein Slows Disease Progression in Pkd1 Knockout Mice.基于小麦的蛋白质可减缓多囊肾病1基因敲除小鼠的疾病进展。
Function (Oxf). 2025 Aug 1;6(4). doi: 10.1093/function/zqaf026.
5
An RNA transmethylation pathway governs kidney nephrogenic potential.一种RNA甲基化途径调控肾脏的肾发生潜能。
Nat Commun. 2025 May 28;16(1):4930. doi: 10.1038/s41467-025-60097-6.
6
The Impact of METTL3 on MDM2 Promotes Podocytes Injury During Diabetic Kidney Disease.METTL3对MDM2的影响促进糖尿病肾病期间足细胞损伤。
J Cell Mol Med. 2025 May;29(10):e70627. doi: 10.1111/jcmm.70627.
7
Cardiovascular Mettl3 Deficiency Causes Congenital Cardiac Defects and Postnatal Lethality in Mice.心血管系统中Mettl3缺乏导致小鼠先天性心脏缺陷和出生后死亡。
Int J Biol Sci. 2025 Mar 10;21(6):2430-2445. doi: 10.7150/ijbs.100941. eCollection 2025.
8
Metabolic reprogramming in polycystic kidney disease and other renal ciliopathies.多囊肾病及其他肾脏纤毛病中的代谢重编程。
EMBO Mol Med. 2025 Apr 22. doi: 10.1038/s44321-025-00239-x.
9
Role of mA RNA methylation in renal resident cell injury.信使核糖核酸甲基化在肾固有细胞损伤中的作用。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 28;49(11):1757-1768. doi: 10.11817/j.issn.1672-7347.2024.230600.
10
Physiologic mechanisms underlying polycystic kidney disease.多囊肾病的生理机制。
Physiol Rev. 2025 Jul 1;105(3):1553-1607. doi: 10.1152/physrev.00018.2024. Epub 2025 Feb 12.
通过限制葡萄糖摄入来延长寿命的作用会被蛋氨酸补充所削弱:葡萄糖和蛋氨酸之间的相互作用以及蛋氨酸作为寿命关键调节剂的意义。
Sci Adv. 2020 Aug 5;6(32):eaba1306. doi: 10.1126/sciadv.aba1306. eCollection 2020 Aug.
4
Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.G 蛋白偶联受体和环 AMP 信号转导对多囊肾病的调节。
Cell Signal. 2020 Aug;72:109649. doi: 10.1016/j.cellsig.2020.109649. Epub 2020 Apr 23.
5
The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.m6A甲基转移酶METTL3通过介导MYC甲基化促进前列腺癌的发生和发展。
J Cancer. 2020 Mar 25;11(12):3588-3595. doi: 10.7150/jca.42338. eCollection 2020.
6
Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.间质微小 RNA miR-214 可减轻炎症和多囊肾病的进展。
JCI Insight. 2020 Apr 9;5(7):133785. doi: 10.1172/jci.insight.133785.
7
Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer.METTL3 的小分子抑制剂,主要的人类转录后修饰写入器。
ChemMedChem. 2020 May 6;15(9):744-748. doi: 10.1002/cmdc.202000011. Epub 2020 Mar 23.
8
METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated mA Modification.METTL3通过YTHDF1介导的m⁶A修饰增强c-Myc稳定性促进口腔鳞状细胞癌肿瘤发生。
Mol Ther Nucleic Acids. 2020 Jun 5;20:1-12. doi: 10.1016/j.omtn.2020.01.033. Epub 2020 Feb 4.
9
The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.主调控因子 Myc 和 p53 在多囊肾病中的细胞信号转导和功能。
Cell Signal. 2020 Jul;71:109594. doi: 10.1016/j.cellsig.2020.109594. Epub 2020 Mar 4.
10
Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.金属蛋白酶 PAPP-A 对 IGF-1 的调节有助于多囊肾病的发病机制。
JCI Insight. 2020 Feb 27;5(4):135700. doi: 10.1172/jci.insight.135700.